InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2025-03-21 00:00:00 ET · period of report 2025-03-19 · accession 0001477449-25-000034 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-21 2025-03-19 TDOC Vandervoort Adam C CLO, Sec M - OptEx — +21.4K 75.3K +40% —
D 2025-03-21 2025-03-20 TDOC Vandervoort Adam C CLO, Sec S - Sale+OE $8.42 -11.0K 64.3K -15% -$92.7K
D 2025-03-21 2025-03-19 TDOC Vandervoort Adam C CLO, Sec M - OptEx $0.00 -21.4K 42.8K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-19 M A 21,400 — 75,319 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2025-03-20 S D 11,011 $8.42 64,308 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2025-03-19 M D 21,400 $0.00 42,800 D — · — to — 21,400 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.